Cargando…

Predisposing factors for late mortality in heart transplant patients

BACKGROUND: Because of the growing prevalence of terminal heart failure on the one hand and organ shortage on the other hand, an optimal care of heart transplant recipients based on the knowledge of potential risk factors not only early, but also in a long-term course after heart transplantation is...

Descripción completa

Detalles Bibliográficos
Autores principales: Alyaydin, Emyal, Welp, Henryk, Reinecke, Holger, Tuleta, Izabela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428941/
https://www.ncbi.nlm.nih.gov/pubmed/32052856
http://dx.doi.org/10.5603/CJ.a2020.0011
_version_ 1783750469158436864
author Alyaydin, Emyal
Welp, Henryk
Reinecke, Holger
Tuleta, Izabela
author_facet Alyaydin, Emyal
Welp, Henryk
Reinecke, Holger
Tuleta, Izabela
author_sort Alyaydin, Emyal
collection PubMed
description BACKGROUND: Because of the growing prevalence of terminal heart failure on the one hand and organ shortage on the other hand, an optimal care of heart transplant recipients based on the knowledge of potential risk factors not only early, but also in a long-term course after heart transplantation is of great importance. Therefore, the aim of the present study was to identify predisposing factors for late mortality in this patient collective. METHODS: Data from long-term heart transplant patients collected during follow-up visits in the current center were retrospectively analyzed. Clinical, laboratory, including immune monitoring and apparative examination results were studied with regard to all-cause mortality. RESULTS: One hundred and seventy-two patients after heart transplantation (mean: 13.2 ± 6.4 years) were divided into two groups: survivors (n = 133) and non-survivors (n = 39). In comparison with survivors, non-survivors were characterized by significantly more pronounced renal insufficiency with more frequent dialysis, anemia and worse functional status. Additionally, non-survivors obtained hearts from relevantly more obese donors. In a multivariate Cox regression analysis the following parameters were shown to be independent risk factors for increased mortality: CD4 percentage < 42%, C-reactive protein ≥ 0.5 mg/dL, presence of rejections requiring therapies in the past, onset of cardiac allograft vasculopathy < 5 years following heart transplantation and no use of beta-blockers. CONCLUSIONS: Low CD4+ cell percentages, sustained inflammation, relevant organ rejections, early onset of transplant vasculopathy and no use of beta-blockers are risk factors for higher mortality in a long-term follow-up after heart transplantation.
format Online
Article
Text
id pubmed-8428941
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-84289412021-09-10 Predisposing factors for late mortality in heart transplant patients Alyaydin, Emyal Welp, Henryk Reinecke, Holger Tuleta, Izabela Cardiol J Clinical Cardiology BACKGROUND: Because of the growing prevalence of terminal heart failure on the one hand and organ shortage on the other hand, an optimal care of heart transplant recipients based on the knowledge of potential risk factors not only early, but also in a long-term course after heart transplantation is of great importance. Therefore, the aim of the present study was to identify predisposing factors for late mortality in this patient collective. METHODS: Data from long-term heart transplant patients collected during follow-up visits in the current center were retrospectively analyzed. Clinical, laboratory, including immune monitoring and apparative examination results were studied with regard to all-cause mortality. RESULTS: One hundred and seventy-two patients after heart transplantation (mean: 13.2 ± 6.4 years) were divided into two groups: survivors (n = 133) and non-survivors (n = 39). In comparison with survivors, non-survivors were characterized by significantly more pronounced renal insufficiency with more frequent dialysis, anemia and worse functional status. Additionally, non-survivors obtained hearts from relevantly more obese donors. In a multivariate Cox regression analysis the following parameters were shown to be independent risk factors for increased mortality: CD4 percentage < 42%, C-reactive protein ≥ 0.5 mg/dL, presence of rejections requiring therapies in the past, onset of cardiac allograft vasculopathy < 5 years following heart transplantation and no use of beta-blockers. CONCLUSIONS: Low CD4+ cell percentages, sustained inflammation, relevant organ rejections, early onset of transplant vasculopathy and no use of beta-blockers are risk factors for higher mortality in a long-term follow-up after heart transplantation. Via Medica 2020-02-11 /pmc/articles/PMC8428941/ /pubmed/32052856 http://dx.doi.org/10.5603/CJ.a2020.0011 Text en Copyright © 2021 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
spellingShingle Clinical Cardiology
Alyaydin, Emyal
Welp, Henryk
Reinecke, Holger
Tuleta, Izabela
Predisposing factors for late mortality in heart transplant patients
title Predisposing factors for late mortality in heart transplant patients
title_full Predisposing factors for late mortality in heart transplant patients
title_fullStr Predisposing factors for late mortality in heart transplant patients
title_full_unstemmed Predisposing factors for late mortality in heart transplant patients
title_short Predisposing factors for late mortality in heart transplant patients
title_sort predisposing factors for late mortality in heart transplant patients
topic Clinical Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428941/
https://www.ncbi.nlm.nih.gov/pubmed/32052856
http://dx.doi.org/10.5603/CJ.a2020.0011
work_keys_str_mv AT alyaydinemyal predisposingfactorsforlatemortalityinhearttransplantpatients
AT welphenryk predisposingfactorsforlatemortalityinhearttransplantpatients
AT reineckeholger predisposingfactorsforlatemortalityinhearttransplantpatients
AT tuletaizabela predisposingfactorsforlatemortalityinhearttransplantpatients